机译:MIB-1,p53,表皮生长因子受体和INI1在儿童脊索瘤中的预后价值
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India;
Department of Pathology, All India Institute of Medical Sciences, New Delhi 110029, India;
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India;
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India;
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India;
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India;
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India;
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India;
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India;
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India;
Department of Neuroradiology, All India Institute of Medical Sciences, New Delhi, India;
Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India;
Genomics and Molecular Medicine, Institute of Genomics and Integrative Biology- Council of Scientific and Industrial Research (IGIB-CSIR), New Delhi, India;
chordoma; clivus; EGFR; INI1; pediatric;
机译:Ki-67,p53,表皮生长因子受体,1p36、9p21、10q23和17p13在颅底脊索瘤中的预后价值
机译:Ki-67,p53,表皮生长因子受体,1p36、9p21、10q23和17p13在颅底脊索瘤中的预后价值。
机译:KI67,p53,人上皮生长因子受体2,拓扑异构酶IIalpha,表皮生长因子受体以及卵巢癌和骨髓中已扩散的肿瘤细胞的nm23表达对预后的影响。
机译:表皮生长因子受体酪氨酸激酶抑制剂ZD1839(Iressa)通过独立于p53和MMP,uPAR依赖性机制抑制人口腔鳞状细胞癌细胞的增殖和侵袭
机译:表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
机译:MIB-1p53表皮生长因子受体和INI1在儿童脊索瘤中的预后价值
机译:多种蛋白质作为结肠直肠癌的预后因子的表达:组织蛋白酶D,P53,COX-2,表皮生长因子受体,C-ERBB-2和Ki-67
机译:乳腺癌:表皮生长因子受体,mDm2和p53突变的参与